These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transfer of modified gut viromes improves symptoms associated with metabolic syndrome in obese male mice. Mao X; Larsen SB; Zachariassen LSF; Brunse A; Adamberg S; Mejia JLC; Larsen F; Adamberg K; Nielsen DS; Hansen AK; Hansen CHF; Rasmussen TS Nat Commun; 2024 Jun; 15(1):4704. PubMed ID: 38830845 [TBL] [Abstract][Full Text] [Related]
3. Faecal microbiota transplantations and the role of bacteriophages. Liu Q; Xu Z; Dai M; Su Q; Leung Chan FK; Ng SC Clin Microbiol Infect; 2023 Jun; 29(6):689-694. PubMed ID: 36414201 [TBL] [Abstract][Full Text] [Related]
4. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease. Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317 [TBL] [Abstract][Full Text] [Related]
5. Bacteriophage-mediated manipulation of the gut microbiome - promises and presents limitations. Rasmussen TS; Koefoed AK; Jakobsen RR; Deng L; Castro-Mejía JL; Brunse A; Neve H; Vogensen FK; Nielsen DS FEMS Microbiol Rev; 2020 Jul; 44(4):507-521. PubMed ID: 32495834 [TBL] [Abstract][Full Text] [Related]
6. Autochthonous faecal viral transfer (FVT) impacts the murine microbiome after antibiotic perturbation. Draper LA; Ryan FJ; Dalmasso M; Casey PG; McCann A; Velayudhan V; Ross RP; Hill C BMC Biol; 2020 Nov; 18(1):173. PubMed ID: 33218339 [TBL] [Abstract][Full Text] [Related]
7. Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile. Kumar R; Maynard CL; Eipers P; Goldsmith KT; Ptacek T; Grubbs JA; Dixon P; Howard D; Crossman DK; Crowley MR; Benjamin WH; Lefkowitz EJ; Weaver CT; Rodriguez JM; Morrow CD BMC Microbiol; 2016 Jan; 16():5. PubMed ID: 26758906 [TBL] [Abstract][Full Text] [Related]
8. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Mullish BH; McDonald JAK; Pechlivanis A; Allegretti JR; Kao D; Barker GF; Kapila D; Petrof EO; Joyce SA; Gahan CGM; Glegola-Madejska I; Williams HRT; Holmes E; Clarke TB; Thursz MR; Marchesi JR Gut; 2019 Oct; 68(10):1791-1800. PubMed ID: 30816855 [TBL] [Abstract][Full Text] [Related]
9. Key determinants of success in fecal microbiota transplantation: From microbiome to clinic. Porcari S; Benech N; Valles-Colomer M; Segata N; Gasbarrini A; Cammarota G; Sokol H; Ianiro G Cell Host Microbe; 2023 May; 31(5):712-733. PubMed ID: 37167953 [TBL] [Abstract][Full Text] [Related]
17. Recovery of the gut microbiome following fecal microbiota transplantation. Seekatz AM; Aas J; Gessert CE; Rubin TA; Saman DM; Bakken JS; Young VB mBio; 2014 Jun; 5(3):e00893-14. PubMed ID: 24939885 [TBL] [Abstract][Full Text] [Related]
18. The success of fecal microbial transplantation in Park H; Laffin MR; Jovel J; Millan B; Hyun JE; Hotte N; Kao D; Madsen KL Gut Microbes; 2019; 10(6):676-687. PubMed ID: 30866714 [No Abstract] [Full Text] [Related]
19. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile. Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776 [TBL] [Abstract][Full Text] [Related]
20. Beyond faecal microbiota transplantation, the non-negligible role of faecal virome or bacteriophage transplantation. Wu D; Zhang C; Liu Y; Yao J; Yang X; Wu S; Du J; Yang X J Microbiol Immunol Infect; 2023 Oct; 56(5):893-908. PubMed ID: 36890066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]